Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
The show earned an 87% critics score on Rotten Tomatoes but just 51% from audiences....
Russia urges Iran to pursue a political settlement amid US-Iran tensions and impacts on oil supply....
